PortfoliosLab logoPortfoliosLab logo
MRN3.L vs. 3APE.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

MRN3.L vs. 3APE.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3.L) and Leverage Shares 3x Apple ETC EUR (3APE.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

MRN3.L is traded in USD, while 3APE.L is traded in EUR. To make them comparable, the 3APE.L values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, MRN3.L achieves a 156.89% return, which is significantly higher than 3APE.L's 29.80% return.


MRN3.L

1D
26.04%
1M
21.33%
YTD
156.89%
6M
287.40%
1Y
64.51%
3Y*
-91.30%
5Y*
10Y*

3APE.L

1D
-1.15%
1M
33.33%
YTD
29.80%
6M
17.74%
1Y
160.23%
3Y*
19.27%
5Y*
23.80%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MRN3.L vs. 3APE.L - Yearly Performance Comparison


2026 (YTD)20252024202320222021
MRN3.L
Leverage Shares 3x Long Moderna (MRNA) ETP Securities
156.89%-93.67%-98.51%-92.76%-92.21%-36.68%
3APE.L
Leverage Shares 3x Apple ETC EUR
29.80%-22.68%67.09%165.81%-75.72%6.88%

Correlation

The correlation between MRN3.L and 3APE.L is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Dec 16, 2021

0.16

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MRN3.L vs. 3APE.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MRN3.L
MRN3.L Risk / Return Rank: 2525
Overall Rank
MRN3.L Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
MRN3.L Sortino Ratio Rank: 4242
Sortino Ratio Rank
MRN3.L Omega Ratio Rank: 3737
Omega Ratio Rank
MRN3.L Calmar Ratio Rank: 1919
Calmar Ratio Rank
MRN3.L Martin Ratio Rank: 1515
Martin Ratio Rank

3APE.L
3APE.L Risk / Return Rank: 6363
Overall Rank
3APE.L Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
3APE.L Sortino Ratio Rank: 6161
Sortino Ratio Rank
3APE.L Omega Ratio Rank: 5555
Omega Ratio Rank
3APE.L Calmar Ratio Rank: 7676
Calmar Ratio Rank
3APE.L Martin Ratio Rank: 5151
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRN3.L vs. 3APE.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3.L) and Leverage Shares 3x Apple ETC EUR (3APE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MRN3.L3APE.LDifference
Sharpe ratioReturn per unit of total volatility

-1.99

Sortino ratioReturn per unit of downside risk

-0.78

Omega ratioGain probability vs. loss probability

1.24

1.34

-0.10

Calmar ratioReturn relative to maximum drawdown

0.79

3.81

-3.02

Martin ratioReturn relative to average drawdown

1.25

8.84

-7.59

MRN3.L vs. 3APE.L - Sharpe Ratio Comparison

The current MRN3.L Sharpe Ratio is 0.30, which is lower than the 3APE.L Sharpe Ratio of 2.30. The chart below compares the historical Sharpe Ratios of MRN3.L and 3APE.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MRN3.L3APE.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.30

2.30

-1.99

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.30

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.43

0.31

-0.74

Drawdowns

MRN3.L vs. 3APE.L - Drawdown Comparison

The maximum MRN3.L drawdown since its inception was -100.00%, which is greater than 3APE.L's maximum drawdown of -78.44%. Use the drawdown chart below to compare losses from any high point for MRN3.L and 3APE.L.


Loading charts...

Drawdown Indicators


MRN3.L3APE.LDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-78.44%

-21.56%

Max Drawdown (1Y)

Largest decline over 1 year

-81.28%

-41.80%

-39.48%

Max Drawdown (3Y)

Largest decline over 3 years

-99.99%

-72.59%

-27.40%

Max Drawdown (5Y)

Largest decline over 5 years

-78.44%

Current Drawdown

Current decline from peak

-100.00%

-2.79%

-97.21%

Average Drawdown

Average peak-to-trough decline

-97.63%

-37.05%

-60.58%

Ulcer Index

Depth and duration of drawdowns from previous peaks

51.56%

18.04%

+33.52%

Volatility

MRN3.L vs. 3APE.L - Volatility Comparison

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3.L) has a higher volatility of 57.82% compared to Leverage Shares 3x Apple ETC EUR (3APE.L) at 15.01%. This indicates that MRN3.L's price experiences larger fluctuations and is considered to be riskier than 3APE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MRN3.L3APE.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

57.82%

15.01%

+42.81%

Volatility (6M)

Calculated over the trailing 6-month period

163.07%

49.91%

+113.16%

Volatility (1Y)

Calculated over the trailing 1-year period

210.95%

69.30%

+141.65%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

221.82%

80.88%

+140.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

221.82%

85.19%

+136.63%

MRN3.L vs. 3APE.L - Expense Ratio Comparison

Both MRN3.L and 3APE.L have an expense ratio of 0.75%.


Dividends

MRN3.L vs. 3APE.L - Dividend Comparison

Neither MRN3.L nor 3APE.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


MRN3.L and 3APE.L have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Both ETFs have the same 0.75% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

MRN3.L and 3APE.L have the same expense ratio: 0.75% per year.

MRN3.L tracks iSTOXX Leveraged 3x MRNA Index, while 3APE.L tracks iSTOXX Leveraged 3X AAPL Index.

Portfolio Optimizer

Find the right allocation for MRN3.L and 3APE.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer